DMXAA5,6-Dimethylxanthenone-4-acetic acid
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Baguley, "Antivascular therapy of cancer: DMXAA," The Lancet Oncology, vol.
In Roche's Pipeline Human Drug Name Condition Research Stage (Subsidiary or alliance company in parenthesis) Bondronat Osteoporosis Tests completed; awaiting federal approval Avastin (Genentech) Colorectal cancer Late-stage tests Pemtumomab (Antisoma) Ovarian cancer Late-stage CERA Anemia Mid-stage Diflomotecan Colorectal, lung, Mid-stage (Beaufour Ipsen) and breast cancer MRA (Chugai) Rheumatoid arthritis Mid-stage NK1 Depression Mid-stage VCAM Asthma Mid-stage [R.sub.45[degrees]] Stress urinary Mid-stage incontinence TheraFab (Antisoma) Cancer Early-stage Therex (Antisoma) Cancer Early-stage DMXAA (Antisoma) Cancer Early-stage Source: Roche
There are three additional products in the clinical pipeline, Therex, DMXAA and TheraFab, and an extensive pre-clinical program.